Filing Details
- Accession Number:
- 0001104659-20-010828
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-04 18:41:15
- Reporting Period:
- 2020-01-31
- Accepted Time:
- 2020-02-04 18:41:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1638381 | Intec Pharma Ltd. | NTEC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1636701 | Dan Oren | 1 Dexcel Street Or Akiva L3 3060000 | No | No | Yes | No | |
| 1720007 | Ltd. Technologies Pharma Dexcel | 1 Dexcel Street Or Akiva L3 3060000 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2020-01-31 | 725,951 | $0.31 | 4,424,897 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2020-02-03 | 80,000 | $0.32 | 4,344,897 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2020-02-04 | 110,000 | $0.29 | 4,234,897 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Dexcel Pharma Technologies Ltd ("DPT") and Dan Oren, DPT's Executive Chairman, are filing this Form 4 because they have beneficial ownership over ordinary shares of Intec Pharma Ltd. The Ordinary Shares are directly owned by DPT. Mr. Oren is ultimately the sole shareholder of DPT.
- The price reported in Column 4 is the weighted average price. The Ordinary Shares were sold in multiple transactions at prices ranging from $0.300 to $0.325, inclusive.
- The price reported in Column 4 is the weighted average price. The Ordinary Shares were sold in multiple transactions at prices ranging from $0.300 to $0.324, inclusive.
- The price reported in Column 4 is the weighted average price. The Ordinary Shares were sold in multiple transactions at prices ranging from $0.290 to $0.294, inclusive.
- The Reporting Persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
